This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Bell's phenomenon

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • Bell's phenomenon
    • occurs in the case of a unilateral lower motor neuron palsy
    • is the visible vertical rotation of globe on closing the affected eye (1)
    • it is seen when the patient attempts to shut the eye on the affected side which causes upward movement of the eyeball and incomplete closure of the eyelid.
    • this provides a test of infranuclear competence
      • only a positive response is helpful
      • some normal subjects do not show a Bell's phenomenon.
    • in unconscious patients, a fairly strong corneal stimulus may induce a Bell's phenomenon. If it does, it indicates midbrain-low pons intactness, i.e. cranial nerves III-VII. With structural brainstem lesions above the pons, Bell's phenomenon disappears but the jaw may deviate to the opposite side in the corneal pterygoid reflex.
  • bilateral Bell's phenomenon (2)
    • is found in the following conditions
      • myasthenia gravis
      • sarcoidosis
      • bilateral Bell's palsies
      • congenital facial diplegia
      • muscular dystrophy
      • motor neuron disease
      • Guillain-Barré syndrome (rare)
  • if an oblique of horizontal ocular deviation is evoked during forcible lid closure, it is said to signify a temporoparietal lesion on the side opposite to the deviation and is called by Cogan 'spasticity of conjugate gaze.'

Reference:


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.